临床儿科杂志 ›› 2022, Vol. 40 ›› Issue (8): 573-579.doi: 10.12372/jcp.2022.22e0133
严永东, 王婷, 滑洁
收稿日期:
2020-12-25
出版日期:
2022-08-15
发布日期:
2022-08-09
基金资助:
YAN Yongdong, WANG Ting, HUA Jie
Received:
2020-12-25
Online:
2022-08-15
Published:
2022-08-09
摘要:
过敏性疾病的患病率在全球范围内呈上升趋势,严重影响了特应性个体的健康和生活质量。越来越多的证据支持肠道微生态失衡与过敏性疾病的发生、发展和转归有关。益生菌可以通过纠正微生态失衡、维持黏膜屏障、调节免疫功能等机制在过敏性疾病防治方面发挥一定作用。文章对近年来益生菌在儿童食物过敏、特应性皮炎、哮喘和变应性鼻炎等方面的研究和应用现状进行梳理和分析,为临床医师提供参考。
严永东, 王婷, 滑洁. 益生菌预防和治疗儿童过敏性疾病的现状[J]. 临床儿科杂志, 2022, 40(8): 573-579.
YAN Yongdong, WANG Ting, HUA Jie. Current status of probiotics for prevention and treatment of allergic diseases in children[J]. Journal of Clinical Pediatrics, 2022, 40(8): 573-579.
[1] |
Haspeslagh E, Heyndrickx I, Hammad H, et al. The hygiene hypothesis: immunological mechanisms of airway tolerance[J]. Curr Opin Immunol, 2018, 54: 102-108.
doi: S0952-7915(18)30021-9 pmid: 29986301 |
[2] | Wang HT, Anvari S, Anagnostou K. The role of probiotics in preventing allergic disease[J]. Children (Basel), 2019, 6(2): 24. |
[3] |
MelliL LC, do Carmo-Rodrigues MS, Araújo-Filho HB, et al. Intestinal microbiota and allergic diseases: a systematic review[J]. Allergol Immunopathol (Madr), 2016, 44(2): 177-188.
doi: 10.1016/j.aller.2015.01.013 |
[4] |
Yao TC, Chang CJ, Hsu YH, et al. Probiotics for allergic diseases: realities and myths[J]. Pediatr Allergy Immunol, 2010, 21(6): 900-919.
doi: 10.1111/j.1399-3038.2009.00955.x |
[5] |
Wopereis H, Oozeer R, Knipping K, et al. The first thousand days - intestinal microbiology of early life: establishing a symbiosis[J]. Pediatr Allergy Immunol, 2014, 25(5): 428-438.
doi: 10.1111/pai.12232 |
[6] | Su YJ, Luo SD, Hsu CY, et al. Differences in gut microbiota between allergic rhinitis, atopic dermatitis, and skin urticaria: a pilot study[J]. Medicine, 2021, 100: 9(e25091). |
[7] |
Durack J, Lynch SV. The gut microbiome: relationships with disease and opportunities for therapy[J]. J Exp Med, 2019, 216(1): 20-40.
doi: 10.1084/jem.20180448 |
[8] |
Dang AT, Marsland BJ. Microbes, metabolites, and the gut-lung axis[J]. Mucosal Immunol, 2019, 12(4): 843-850.
doi: 10.1038/s41385-019-0160-6 pmid: 30976087 |
[9] |
Trompette A, Gollwitzer ES, Yadava K, et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis[J]. Nat Med, 2014, 20(2): 159-166.
doi: 10.1038/nm.3444 pmid: 24390308 |
[10] |
O'neill CA, Monteleone G, McLaughlin JT, et al. The gut-skin axis in health and disease: a paradigm with therapeutic implications[J]. Bioessays, 2016, 38(11): 1167-1176.
doi: 10.1002/bies.201600008 |
[11] |
De Pessemier B, Grine L, Debaere M, et al. Gut-skin axis: current knowledge of the interrelationship between microbial dysbiosis and skin conditions[J]. Microorganisms, 2021, 9(2): 353.
doi: 10.3390/microorganisms9020353 |
[12] |
Ojeda J, Ávila A, Vidal PM. Gut Microbiota interaction with the central nervous system throughout life[J]. J Clin Med, 2021, 10(6): 1299.
doi: 10.3390/jcm10061299 |
[13] |
Hill C, Guarner F, Reid G, et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics Consensus statement on the scope and appropriate use of the term probiotic[J]. Nat Rev Gastroenterol Hepatol, 2014, 11(8): 506-514.
doi: 10.1038/nrgastro.2014.66 |
[14] | Plaza-Diaz J, Ruiz-Ojeda FJ, Gil-Campos M, et al. Mechanisms of action of probiotics[J]. Adv Nutr, 2019, 10(Suppl 1): S49-S66. |
[15] |
Stavropoulou E, Bezirtzoglou E. Probiotics in medicine: a long debate[J]. Front Immunol, 2020, 11: 2192.
doi: 10.3389/fimmu.2020.02192 pmid: 33072084 |
[16] |
Koplin JJ, Peters RL, Allen KJ. Prevention of food allergies[J]. Immunol Allergy Clin North Am, 2018, 38(1): 1-11.
doi: 10.1016/j.iac.2017.09.001 |
[17] |
Zhang GQ, Hu HJ, Liu CY, et al. Probiotics for prevention of atopy and food hypersensitivity in early childhood: a PRISMA-compliant systematic review and meta-analysis of randomized controlled trials[J]. Medicine (Baltimore), 2016, 95(8): e2562.
doi: 10.1097/MD.0000000000002562 |
[18] |
Halken S, Muraro A, de Silva D, et al. EAACI guideline: preventing the development of food allergy in infants and young children (2020 update)[J]. Pediatr Allergy Immunol, 2021, 32(5): 843-858.
doi: 10.1111/pai.13496 |
[19] |
Berni Canani R, Di Costanzo M, Bedogni G, et al. Extensively hydrolyzed casein formula containing Lactobacillus rhamnosus GG reduces the occurrence of other allergic manifestations in children with cow's milk allergy: 3-year randomized controlled trial[J]. J Allergy Clin Immunol, 2017, 139(6): 1906-1913.
doi: 10.1016/j.jaci.2016.10.050 |
[20] |
Hsiao KC, Ponsonby AL, Axelrad C, et al. Long-term clinical and immunological effects of probiotic and peanut oral immunotherapy after treatment cessation: 4-year follow-up of a randomised, double-blind, placebocontrolled trial[J]. Lancet Child Adolesc Health, 2017, 1(2): 97-105.
doi: 10.1016/S2352-4642(17)30041-X |
[21] |
Santos SCD, Konstantyner T, Cocco RR. Effects of probiotics in the treatment of food hypersensitivity in children: a systematic review[J]. Allergol Immunopathol (Madr), 2020, 48(1): 95-104.
doi: 10.1016/j.aller.2019.04.009 |
[22] |
Fang Z, Li L, Zhang H, et al. Gut microbiota, probiotics, and their interactions in prevention and treatment of atopic dermatitis: a review[J]. Front Immunol, 2021, 12: 720393.
doi: 10.3389/fimmu.2021.720393 |
[23] |
Li L, Han Z, Niu X, et al. Probiotic supplementation for prevention of atopic dermatitis in infants and children: a systematic review and meta-analysis[J]. Am J Clin Dermatol, 2019, 20(3): 367-377.
doi: 10.1007/s40257-018-0404-3 |
[24] | Amalia N, Orchard D, Francis KL, et al. Systematic review and meta-analysis on the use of probiotic supplementation in pregnant mother, breastfeeding mother and infant for the prevention of atopic dermatitis in children[J]. Australas J Dermatol, 2020, 61(2): e158-e173. |
[25] | Sun SY, Chang GZ, Zhang LT. The prevention effect of probiotics against eczema in children: an update systematic review and meta-analysis[J]. J Dermatolog Treat, 2021, 18: 1-11. |
[26] |
Jiang W, Ni B, Liu Z, et al. The role of probiotics in the prevention and treatment of atopic dermatitis in children: an updated systematic review and meta-analysis of randomized controlled trials[J]. Paediatr Drugs, 2020, 22(5): 535-549.
doi: 10.1007/s40272-020-00410-6 pmid: 32748341 |
[27] |
Azad MB, Coneys JG, Kozyrskyj AL, et al. Probiotic supplementation during pregnancy or infancy for the prevention of asthma and wheeze: systematic review and meta-analysis[J]. BMJ, 2013, 347: f6471.
doi: 10.1136/bmj.f6471 |
[28] |
Peldan P, Kukkonen AK, Savilahti E, et al. Perinatal probiotics decreased eczema up to 10 years of age, but at 5-10 years, allergic rhino-conjunctivitis was increased[J]. Clin Exp Allergy, 2017, 47(7): 975-979.
doi: 10.1111/cea.12924 pmid: 28316095 |
[29] |
Wei XC, Jiang P, Liu JB, et al. Association between probiotic supplementation and asthma incidence in infants: a meta-analysis of randomized controlled trials[J]. J Asthma, 2020, 57(2): 167-178.
doi: 10.1080/02770903.2018.1561893 |
[30] |
Du X, Wang L, Wu S, et al. Efficacy of probiotic supplementary therapy for asthma, allergic rhinitis, and wheeze: a meta-analysis of randomized controlled trials[J]. Allergy Asthma Proc, 2019, 40(4): 250-260.
doi: 10.2500/aap.2019.40.4227 |
[31] |
Huang CF, Chie WC, Wang IJ. Efficacy of Lactobacillus administration in school-age children with asthma: a randomized, placebo-controlled trial[J]. Nutrients, 2018, 10(11): 1678.
doi: 10.3390/nu10111678 |
[32] | Drago L, Cioffi L, Giuliano M, et al. The probiotics in pediatric asthma management (PROPAM) study in the primary care setting: a randomized, controlled, double-blind trial with Ligilactobacillus salivarius LS01 (DSM22775) and Bifidobacterium breve B632 (DSM 24706)[J]. J Immunol Res, 2022, 2022: 3837418. |
[33] |
Bertelsen RJ, Brantsaeter AL, Magnus MC, et al. Probiotic milk consumption in pregnancy and infancy and subsequent childhood allergic diseases[J]. J Allergy Clin Immunol, 2014, 133(1): 165-171.
doi: 10.1016/j.jaci.2013.07.032 pmid: 24034345 |
[34] |
Meirlaen L, Levy EI, Vandenplas Y. Prevention and management with pro-, pre and synbiotics in children with asthma and allergic rhinitis: a narrative review[J]. Nutrients, 2021, 13(3): 934.
doi: 10.3390/nu13030934 |
[35] |
Anania C, Di Marino VP, Olivero F, et al. Treatment with a probiotic mixture containing Bifidobacterium animalis Subsp. Lactis BB12 and Enterococcus faecium L3 for the prevention of allergic rhinitis symptoms in children: a randomized controlled trial[J]. Nutrients, 2021, 13(4): 1315.
doi: 10.3390/nu13041315 |
[36] | Chen N, Liu F, Gao Q, et al. A meta-analysis of probiotics for the treatment of allergic airway diseases in children and adolescents[J]. Am J Rhinol Allergy, 2022: 19458924221080159. |
[37] | Nabil F, Elbehedy EM, Sedeek R, et al. Clinical efficacy of combined probiotics and immunotherapy in childhood allergic rhinitis[J]. Egypt J Immunol, 2020, 27(2): 73-79. |
[38] | 吴炜倩, 陆合, 郭亚楠, 等. 益生菌防治过敏性疾病的进展和展望[J]. 中国微生态学杂志, 2020, 32(7): 862-865. |
[39] |
McFarland LV. Efficacy of singlestrain probiotics versus multistrain mixtures: systematic review of strain and disease specificity[J]. Dig Dis Sci, 2021, 66(3): 694-704.
doi: 10.1007/s10620-020-06244-z |
[40] | Spacova I, Ceuppens JL, Seys SF, et al. Probiotics against airway allergy: host factors to consider[J]. Dis Model Mech, 2018, 11(7): dmm034314. |
[41] |
Kallio S, Kukkonen AK, Savilahti E, et al. Perinatal probiotic intervention prevented allergic disease in a Caesarean-delivered subgroup at 13-year follow-up[J]. Clin Exp Allergy, 2019, 49(4): 506-515.
doi: 10.1111/cea.13321 pmid: 30472801 |
[42] |
Jamalkandi SA, Ahmadi A, Ahrari I, et al. Oral and nasal probiotic administration for the prevention and alleviation of allergic diseases, asthma and chronic obstructive pulmonary disease[J]. Nutr Res Rev, 2021, 34(1): 1-16.
doi: 10.1017/S0954422420000116 |
[43] |
van Reenen CA, Dicks LM. Horizontal gene transfer amongst probiotic lactic acid bacteria and other intestinal microbiota: what are the possibilities? A review[J]. Arch Microbiol, 2011, 193(3): 157-168.
doi: 10.1007/s00203-010-0668-3 pmid: 21193902 |
[44] | Doron S, Snydman DR. Risk and safety of probiotics[J]. Clin Infect Dis, 2015, 60(Suppl 2): S129-S134. |
[45] |
Fiocchi A, Pawankar R, Cuello-Garcia C, et al. World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): probiotics[J]. World Allergy Organ J, 2015, 8(1): 4.
doi: 10.1186/s40413-015-0055-2 |
[1] | 邹丽萍. 儿童脑病:一类与各种疾病都相关的疾病[J]. 临床儿科杂志, 2023, 41(9): 641-643. |
[2] | 张炜华, 邹丽萍, 任海涛, 关鸿志. 警惕儿童自身免疫性脑炎诊治陷阱[J]. 临床儿科杂志, 2023, 41(9): 644-649. |
[3] | 侯池, 陈文雄, 廖寅婷, 吴文晓, 田杨, 朱海霞, 彭炳蔚, 曾意茹, 吴汶霖, 陈宗宗, 李小晶. 儿童自身免疫性胶质纤维酸性蛋白星形胶质细胞病临床分析[J]. 临床儿科杂志, 2023, 41(9): 656-660. |
[4] | 杨雅婷, 蔡玥昊, 方琼, 陈琅, 陈巧彬, 林志, 吴菲菲, 林萌. 儿童特发性和症状性枕叶癫痫临床分析[J]. 临床儿科杂志, 2023, 41(9): 668-673. |
[5] | 侯若琳, 吴静, 李玲. 头颅MRI以脑膜增厚伴强化表现的儿童自身免疫性脑炎[J]. 临床儿科杂志, 2023, 41(9): 674-679. |
[6] | 武跃芳, 孙艳玲, 武万水, 杜淑旭, 李苗, 孙黎明. G4型髓母细胞瘤患儿预后影响因素及生存状况分析[J]. 临床儿科杂志, 2023, 41(9): 686-691. |
[7] | 孙娟, 李海英, 贾沛生, 王怀立. 儿童暴发性心肌炎12例临床分析[J]. 临床儿科杂志, 2023, 41(9): 692-696. |
[8] | 汪陈慧, 杨辉. 儿童克罗恩病早期筛查和诊断研究进展[J]. 临床儿科杂志, 2023, 41(9): 708-714. |
[9] | 沈楠, 杜白露. 血液肿瘤患儿侵袭性真菌感染诊治和管理策略[J]. 临床儿科杂志, 2023, 41(8): 571-577. |
[10] | 徐贝雪, 刘泉波. 儿童侵袭性肺部真菌感染195例临床分析[J]. 临床儿科杂志, 2023, 41(8): 584-588. |
[11] | 陈虹宇, 刘梓豪, 王和平, 廖翠娟, 李莉, 王文建, 赖建威. 不可分型流感嗜血杆菌生物膜在儿童慢性肺部感染中的作用[J]. 临床儿科杂志, 2023, 41(8): 589-593. |
[12] | 康磊, 郭芳, 李立方, 白新凤, 程彩云, 徐梅先. 宏基因组二代测序在儿童内脏利什曼病相关噬血淋巴组织细胞增生症中的应用价值[J]. 临床儿科杂志, 2023, 41(8): 594-598. |
[13] | 邬晓玲, 吕铁伟. 儿童特发性左室室性心动过速临床分析[J]. 临床儿科杂志, 2023, 41(8): 599-603. |
[14] | 孙智才, 刘玉玲, 李小琳, 潘晓芬. 儿童原发性肾病综合征合并肾上腺危象15例临床分析[J]. 临床儿科杂志, 2023, 41(8): 610-612. |
[15] | 王红霞, 潘翔, 逯军. DHTKD1基因复合杂合变异致α-酮己二酸尿症1例报告[J]. 临床儿科杂志, 2023, 41(8): 624-628. |
|